Aaron Gerds, MD, Hematology, Cleveland, OH, Cleveland Clinic

AaronThomasGerdsMDMS

Hematology Cleveland, OH

Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology

Assistant Professor, Medicine, Cleveland Clinic Learner College of Medicine of Case Western Reserve

Overview of Dr. Gerds

Dr. Aaron Gerds completed his undergraduate degree with honors (B.A. in biology and chemistry) at Hope College in Holland, Michigan. He then obtained his M.D. from Loyola University Chicago Stritch School of Medicine. Dr. Gerds stayed at Loyola University Hospital for his Internal Medicine residency training where he also served as chief resident. This is when he first became interested in hematology while analyzing the results of clinical trials under the mentorship of Dr. Patrick Stiff. This experience led him to pursue a master’s degree in clinical research methods and epidemiology during residency. Dr. Gerds then went to Seattle where he completed his hematology/oncology fellowship at the University of Washington, Fred Hutchinson Cancer Research Center. During his fellowship, he was awarded the ASBMT’s New Investigator Award. Under the mentorship of Drs. Joachim Deeg and Bart Scott, Dr. Gerds subspecialized in treating patients with myeloproliferative neoplasms (MPNs) such as polycythemia vera (PV), essential thrombocythemia (ET), myelofibrosis (MF), as well as myelodsyplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML), with a special emphasis on allogeneic hematopoietic cell transplantation. Dr. Gerds is also an active member of the American Society of Hematology, participating in both the Advocacy Leadership Institute and Clinical Research Training Institute, as well as serving on the Test Materials Development Committee. As Assistant Professor in Medicine (Hematology and Medical Oncology) at the Cleveland Clinic Taussig Cancer Institute, Dr. Gerds serves as the principle investigator for a number of clinical trials for the treatment of MPNs, and is focused on developing novel therapies for these patients.

Education & Training

  • University of Washington
    University of WashingtonFELLOWSHIP
  • Loyola University ChicagoOTHER_TRAINING
  • Loyola University
    Loyola UniversityRESIDENCY
  • Loyola University Chicago Stritch School of Medicine
    Loyola University Chicago Stritch School of MedicineMEDICAL_SCHOOL
  • Hope CollegeOTHER_TRAINING

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2013 - 2021
  • WA State Medical License
    WA State Medical License 2010 - 2014
  • IL State Medical License
    IL State Medical License 2006 - 2011
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • New Investigator Award American Society for Blood and Marrow Transplantation, 2013
  • Scholar, Clinical Research Training Course American Society for Blood and Marrow Transplantation, 2012
  • Alpha Omega Alpha Loyola University Stritch School of Medicine, 2010
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Prognostic significance of pre-transplant quality of life in allogeneic hematopoietic cell transplantation recipients  
    Hamilton BK, Law AD, Rybicki L, Abounader D, Dabney J, Dean R, Duong HK, Gerds AT, Hanna R, Hill BT, Jagadeesh D, Kalaycio ME, Lawrence C, McLellan L, Pohlman B, Sobec..., Bone Marrow Transplant, 1/1/2015
  • Lactone synthesis via biotransformations of Gamma-hydroxyamides  
    Taylor, S.K., Arnold, C.R., Gerds A.T., Ide, N.D., Law K.M., Kling, D.L., Pridgeon M.G., Simons, L.J., Vyvyan, J.R., Yamaoka, J.S., Liao, M.K., Goyne, T.E., Tetrahedron: Asymmetry, 1/1/2004

Abstracts/Posters

  • Interactions between Donor Activating Killer Immunoglobulin-like Receptors (KIRs) and Somatic Mutations and Their Association with Outcomes after Allogeneic Hematopoie...
    Aaron T. Gerds, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Identifying Factors That Predict for Unplanned Readmissions for Acute Myeloid Leukemia Patients Receiving Consolidation Cytarabine Based Therapies
    Aaron T. Gerds, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Inotuzumab Ozogamicin Post-Transplant for Acute Lymphocytic Leukemia
    Aaron T. Gerds, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • Disease and Clinical Characteristics of Patients with Myelofibrosis Enrolled in the MOST Study 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Defining Treatment Strategies for MDS/MPN Overlap Syndromes 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Social Media for the Hematologist: Today and in the Future 
    60th American Society of Hematology Annual Meeting - 12/2/2018
  • Join now to see all

Other

Press Mentions

  • Dr. Gerds on Luspatercept to Treat Anemia in Myelofibrosis
    Dr. Gerds on Luspatercept to Treat Anemia in MyelofibrosisFebruary 24, 2020
  • Luspatercept Lowers the Transfusion Burden in Patients with Myelofibrosis-Associated Anemia
    Luspatercept Lowers the Transfusion Burden in Patients with Myelofibrosis-Associated AnemiaFebruary 19, 2020
  • Dr. Gerds on Addressing Anemia in Myelofibrosis
    Dr. Gerds on Addressing Anemia in MyelofibrosisJanuary 27, 2020
  • Join now to see all

Professional Memberships

Hospital Affiliations